top of page
Lupus Clinical GuidancE

The CITE lupus clinical guidance documents provide healthcare professionals with evidence-based recommendations for the diagnosis, assessment, and management of patients with lupus. These guidance documents are developed by an expert panel of clinicians who evaluate the available literature and develop consensus-based recommendations based on the best available evidence.

 

Lupus is a complex and often unpredictable autoimmune disease that can affect multiple organs and systems in the body. The symptoms and severity of lupus can vary widely from patient to patient, and there is currently no cure for the disease. As a result, clinical guidance documents play an important role in helping healthcare professionals navigate the challenges of diagnosing and treating patients with lupus.

There are currently two CITE lupus clinical guidance documents. The topics are:

  • Lupus Nephritis

  • The Appropriate use of Hydroxychloroquine 

Authors:

Ann Clarke, MD MSc FRCPC

Professor, Division of Rheumatology, Department of Medicine

University of Calgary, Calgary AB

Stephanie Keeling, MD MSc FRCPC

Associate Professor of Medicine in the Division of Rheumatology

University of Alberta, Edmonton AB

Mark Matsos, MD FRCPC

Associate Professor, Division of Rheumatology, Department of Medicine

McMaster University, Hamilton ON

Christine Peschken, MD MSc FRCPC

Professor of Medicine and Community Health Sciences, Rady Faculty of Health Sciences, Head, Section of Rheumatology
University of Manitoba, Winnipeg MB 

  

Zahi Touma, MD PhD FRCPC

Associate Professor of Medicine, University of Toronto
Clinician-Scientist, Rheumatology, University Health Network and Mount Sinai Hospital, Toronto ON

Konstantinos Tselios, MD PhD FRCPC

Assistant Professor, Division of Rheumatology, Department of Medicine

McMaster University, Hamilton ON

Michael Walsh, MD MSc PhD FRCPC

Assistant Professor of Medicine (Nephrology) and Clinical Epidemiology and Biostatistics    

McMaster University, Hamilton ON     

This initiative has been sponsored in part by GlaxoSmithKline through an educational grant.

bottom of page